MUSC health has established the Rena N. Grant Sickle Cell Center to help treat those suffering from sickle cell disease. This ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

On this episode, an infant with a harrowing diagnosis defies all odds after receiving a $2 million genetic treatment. Then, a ...

Using protein structure prediction tools, researchers have uncovered receptor structure-function relationships to improve ...

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...